| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bffb5a91296a0c77fde8fde27b9aa13 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L77-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-06 |
| filingDate |
2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10202c4347ac1c3cbe45d9ec57a37259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7e5f0cf8a45e4fc3881897ebbbb2dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6ff00a59871c45f9ef88f8b96417e3c |
| publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10596303-B2 |
| titleOfInvention |
Drug-eluting medical device |
| abstract |
The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12. |
| priorityDate |
2009-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |